Your browser doesn't support javascript.
loading
Design and novel synthetic approach supported with molecular docking and biological evidence for naphthoquinone-hydrazinotriazolothiadiazine analogs as potential anticancer inhibiting topoisomerase-IIB.
Mohamady, Samy; Gibriel, Abdullah Ahmed; Ahmed, Mahmoud Salama; Hendy, Moataz S; Naguib, Bassem H.
Afiliação
  • Mohamady S; Pharmaceutical Chemistry Department, Faculty of Pharmacy, The British University in Egypt, Cairo, Egypt; Center of Drug Research and Development (CDRD), The British University in Egypt, Cairo, Egypt. Electronic address: samy.mohamady@bue.edu.eg.
  • Gibriel AA; Center of Drug Research and Development (CDRD), The British University in Egypt, Cairo, Egypt; Biochemistry & Molecular Biology Department, Faculty of Pharmacy, The British University in Egypt, Cairo, Egypt.
  • Ahmed MS; Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: mahmoud.ahmed@utsouthwestern.edu.
  • Hendy MS; Pharmaceutical Chemistry Department, Faculty of Pharmacy, The British University in Egypt, Cairo, Egypt; Center of Drug Research and Development (CDRD), The British University in Egypt, Cairo, Egypt.
  • Naguib BH; Pharmaceutical Chemistry Department, Faculty of Pharmacy, The British University in Egypt, Cairo, Egypt; Center of Drug Research and Development (CDRD), The British University in Egypt, Cairo, Egypt; Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Bioorg Chem ; 96: 103641, 2020 03.
Article em En | MEDLINE | ID: mdl-32032844

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Naftoquinonas / Inibidores da Topoisomerase II / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Bioorg Chem Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Naftoquinonas / Inibidores da Topoisomerase II / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Bioorg Chem Ano de publicação: 2020 Tipo de documento: Article